For example, while we did not observe an association between alcohol consumption and past-year use of GLP-1 and GLP-1/GIP medications, it is possible that those who used these medications initially had higher consumption but experienced reductions in alcohol consumption between initiating medication use and completing the survey [8]
A decline in ACE2 function in aged individuals, coupled with the age-associated deterioration in mitochondrial functions results in chronic metabolic disorders like diabetes or cancer, and predisposes the host for increased susceptibility to infection, vulnerability to health complications, and intensifies the risk of mortality 163
However, Tirzepatide leads in weight loss effectiveness, typically achieving a reduction of 15-17%
What can I expect during the treatment
Inclusion criteria were T2D diagnosis, 18 years, baseline A1c 8%, with the first FSL acquisition between 2018 and 2022